Ensuring timely completion of post-approval studies and enforcing appropriate regulatory actions based on negative trial results is necessary to minimize patient exposure to ineffective and ...

Combination treatment with a PARP inhibitor and an anti-angiogenic agent did not improve PFS when compared to chemotherapy or a PARP inhibitor alone.

The Trump administration is attempting to slash NIH funding, terminate research grants, and reduce the agency’s workforce.

The rising trajectory in the inability to pay for health care is a disturbing trend that is likely to continue and even accelerate,” said Tim Lash.

Artificial intelligence (AI) can accurately suggest appropriate adjuvant treatment for patients with early breast cancer, according to research published in JCO Clinical Cancer Informatics.

A federal judge has stopped the Trump administration from cutting $11 billion in public health funding -- at least for now.

On April 1, the Trump administration slashed the organization that supported that research — the Agency for Healthcare ...

Partial nephrectomy provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC), according to research presented at the 40th ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

Clinical guidelines should establish clear timelines, and health care systems should prioritize timely treatment initiation and completion,” researchers concluded.

In a survey last year by the American Medical Association, 93% of doctors said that insurers’ prior authorization practices ...

More than 3.8 million US lung cancer deaths were averted during 1970-2022 due to tobacco control, researchers say.